Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 2 minute read Healthcare Industry News Shocking: Olympus CEO Kaufmann resigns amid explosive drug allegations In a major upheaval, Olympus Corporation’s President and CEO, Stefan Kaufmann, resigned amid allegations of illegal drug purchases,… byPallavi MadhirajuOctober 28, 2024